drugset / Trial / NCT07050212
Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
RandomizedParallel-groupTriple-blindPrevention
Summary
By comparing the application effects of three drugs in pediatric preoperative sedation, this study explores the optimal medication regimen, aiming to provide safer, more effective, and more personalized medication options for pediatric preoperative sedation. Additionally, this research will also focus on the impact of these three drugs on postoperative agitation in children, offering valuable references for the overall management of pediatric surgical anesthesia.
Timeline
- Start
- 2025-04-01
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intravenous |
| Comparator | Esketamine | Other / unclassified | 0.5 mg/kg | Intravenous |
| Subject | Remimazolam | Small molecule | 0.3 mg/kg | Intravenous |
Indications
No indication recorded.